HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
RVMD
Revolution Medicines Inc
Healthcare Biotechnology · California, USA · Reports in usd
Market Cap: $28.10B
Market Cap
$28.10B
Enterprise Val
$26.63B
P/E Ratio
-20.49
P/B Ratio
18.74
Trailing PEG (1Y)
-0.20
As Of
May 7, 2026

Overview & Key Metrics

Reporting period: Mar 31, 2026 · Q1 2026
Book Value$1.50B
Return on Equity-83.22%
Return on Assets-59.06%
Current Ratio6.80
Debt/Equity0.29
LT Debt/Equity0.28
Revenue Per Share0.00

Income Statement

Mar 31, 2026
Revenue$0.00
Cost of Revenue$0.00
Gross Profit$0.00
R&D$344.0M
SG&A$101.3M
Operating Expenses$445.2M
Operating Income-$445.2M
Interest Expense$12.2M
Tax Expense$0.00
Net Income-$453.8M
EPS (Basic)$-2.29
EPS (Diluted)$-2.29
EBIT-$441.6M
EBITDA-$437.1M
Consolidated Income-$453.8M
Non-Controlling Interests$0.00

Balance Sheet

Mar 31, 2026
Cash & Equivalents$445.8M
Accounts Receivable$0.00
Inventory$0.00
Current Assets$1.97B
LT Investments$34.7M
Property, Plant & Equipment$161.4M
Intangibles$70.4M
Non-Current Assets$285.8M
Total Assets$2.25B
Accounts Payable$80.5M
Current Debt$16.6M
Current Liabilities$289.6M
LT Debt$420.7M
Non-Current Liabilities$464.2M
Total Liabilities$753.8M
Total Debt$437.3M
Retained Earnings-$3.32B
Shareholder Equity$1.50B
Shares Outstanding198,173,397

Cash Flow Statement

Mar 31, 2026
Operating Cash Flow-$354.2M
Investing Cash Flow$172.6M
Financing Cash Flow$238.7M
CapEx-$1.5M
Free Cash Flow-$355.7M
Depreciation & Amort.$4.5M
Stock-Based Comp$87.3M
Acquisitions / Disposals$0.00
Investment Activity$174.2M
Debt Issued/Repaid$0.00
Equity Issued/Repaid$238.9M
Dividends Paid$0.00
Net Change in Cash$57.2M
Data cached · Meta live · Daily live · Statements live · TTL 24h